002393 Tianjin Lisheng Pharmaceutical
- 17.80
- +0.02+0.11%
Tianjin Lisheng Pharmaceutical News
Lisheng Pharmaceuticals: Report for the third quarter of 2024
Lisheng Pharmaceuticals: Announcement on approval of the marketing license application for the chemical raw material apomiste
Lisheng Pharmaceutical: Announcement of Tianjin Lisheng Pharmaceutical Co., Ltd. on the progress of the company\'s use of idle own funds for cash management
Lisheng Pharmaceutical: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders
Lisheng Pharmaceutical: Legal Opinion on the 2024 Second Extraordinary General Meeting of Shareholders of Tianjin Lisheng Pharmaceutical Co., Ltd.
Lisheng Pharmaceuticals: Announcement on Participating in the 2024 Semi-Annual Report Performance Briefing and Online Investor Reception Day Event for Listed Companies in Tianjin
Tianjin Lisheng Pharmaceutical: Notice Regarding the Holding of the Second Extraordinary Shareholders' Meeting in 2024.
Tianjin Lisheng Pharmaceutical: Special report on the deposit and use of funds raised for the first half of 2024
Tianjin Lisheng Pharmaceutical: Summary of Half-Year Report in 2024.
Tianjin Lisheng Pharmaceutical: Announcement Regarding the Application for Market Approval of Propranolol Hydrochloride Active Pharmaceutical Ingredient
Tianjin Lisheng Pharmaceutical: Financial Report for the first half of 2024.
Tianjin Lisheng Pharmaceutical: Announcement of the resolution of the Supervisory Board on the semi-annual report.
Tianjin Lisheng Pharmaceutical: Half-year report for the year 2024.
Tianjin Lisheng Pharmaceutical: Summary table of non-operating funds utilization and other related funds flow for the first half of the year.
Tianjin Lisheng Pharmaceutical: Company Bylaws (August 2024)
Tianjin Lisheng Pharmaceutical: Announcement of Board of Directors' resolution for semi-annual report.
Tianjin Lisheng Pharmaceutical: Opinions reviewed at the sixth special meeting of independent directors in 2024
Tianjin Lisheng Pharmaceutical: The opinion of the Supervisory Board regarding the verification of the repurchase and cancellation of restricted stocks that have been granted but have not yet been released from trading restrictions for the incentive targets.
Tianjin Lisheng Pharmaceutical: Legal opinion of Tianjin Jinuo Law Firm regarding the matter of Tianjin Lisheng Pharmaceutical Co., Ltd.'s repurchase and cancellation of restricted stocks that have been granted but not yet released from the restriction.
Tianjin Lisheng Pharmaceutical: Announcement Regarding the Reduction of Restricted Stocks Subject to Buyback and Cancellation, Decrease of Registered Capital and Notice to Creditors.
Analysis
Price Target
No Data
No Data